The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis
Abstract
PURPOSE OF REVIEW: The "response to retention" hypothesis of atherosclerosis suggests that the arterial deposition of cholesterol is directly proportional to the concentration of circulating plasma lipoproteins. However, there is increasing evidence to support the concept that specific lipoproteins may be preferentially retained within the arterial wall, possibly as a result of greater affinity for cell surface and extracellular matrices. RECENT FINDINGS: Recently, key studies have provided insight into mechanisms involved in the interaction of apolipoprotein B (apoB)-containing lipoproteins with extracellular matrices. In addition, novel methods and innovative experimental design has enabled us to differentiate between the delivery, retention and efflux of apoB(48)- and apoB(100)-containing lipoproteins. Other studies have demonstrated a relationship between extracellular matrix proteoglycan expression and the development of atherosclerosis. Discussion in the present review also extends to the mechanisms that are involved in the relative intimal retention of apoB(48)- and apoB(100)-containing lipoproteins in order to explain the atherogenicity of these macromolecules. SUMMARY: The perspective of this review is to highlight recent advances in the area of arterial lipoprotein retention and the physiological significance these processes may have in the aetiology of cardiovascular disease. Importantly, an understanding of the mechanisms responsible for the retention of apoB(48)/B(100)-containing lipoproteins will enable new strategies to be developed for the future management of cardiovascular disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Subendothelial retention of atherogenic lipoproteins in early atherosclerosis
Skålén, K., Gustafsson, M., Rydberg, E. K., Hultén, L. M., Wiklund, O., Innerarity, T. L., & Borén, J. (2002) · Nature · doi:10.1038/nature00804 · Cited by 1,019
The response‐to‐retention hypothesis of atherogenesis reinforced
Williams, K. J., & Tabas, I. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00012 · Cited by 395
Nordestgaard, B. G., Wootton, R., & Lewis, B. (1995) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.15.4.534 · Cited by 334
Markers of triglyceride-rich lipoprotein remnant metabolism in visceral obesity
Chan, D. C., Watts, G. F., Barrett, P. H., Mamo, J. C., & Redgrave, T. G. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.2.278 · Cited by 117
Self-citationOlin-Lewis, K., Benton, J. L., Rutledge, J. C., Baskin, D. G., Wight, T. N., & Chait, A. (2002) · Circulation Research · doi:10.1161/01.res.0000024691.82864.f0 · Cited by 19
Research works printed but not linked: 76
- Ross, 1999, Am Heart J, 138, S419, 10.1016/S0002-8703(99)70266-8 · DOI · Paper page
- Mamo, 1997, Clin Exp Pharmacol Physiol, 24, 288, 10.1111/j.1440-1681.1997.tb01822.x · DOI
- Steinberg, 1999, JAMA, 282, 2043, 10.1001/jama.282.21.2043 · DOI · Paper page
- Gotto Jr, 2002, Am J Med, 112, 10S, 10.1016/S0002-9343(02)01085-9 · DOI
- Steiner, 2001, Curr Opin Lipidol, 12, 611, 10.1097/00041433-200112000-00003 · DOI
- Krauss, 2001, J Nutr, 131, 340S, 10.1093/jn/131.2.340S · DOI
- Krauss, 2002, JAMA, 287, 712, 10.1001/jama.287.6.712 · DOI
- Yu, 2001, Front Biosci, 6, D332, 10.2741/Yu · DOI
- Tomkin, 2001, Diabetes Metab Res Rev, 17, 27, 10.1002/dmrr.179 · DOI
- Camejo, 1998, Atherosclerosis, 139, 205, 10.1016/S0021-9150(98)00107-5 · DOI · Paper page
- Camejo, 2002, Atherosclerosis Suppl, 3, 3, 10.1016/S1567-5688(01)00005-8 · DOI
- Pentikainen, 2002, Aterioscler Thromb Vasc Biol, 22, 211, 10.1161/hq0102.101551 · DOI
- Boren, 2000, Curr Opin Lipidol, 11, 451, 10.1097/00041433-200010000-00002 · DOI
- Proctor, 1998, Euro J Clin Invest, 28, 497, 10.1046/j.1365-2362.1998.00317.x · DOI
- Mamo, 1998, Atherosclerosis, 141, S63, 10.1016/S0021-9150(98)00220-2 · DOI
- Proctor, 2001, Arterioscler Thromb Vasc Biol, 21, 653
- Ross, 1994, Annu Rev Physiol, 57, 791, 10.1146/annurev.ph.57.030195.004043 · DOI · Paper page
- Ross, 1993, Nature, 362, 801, 10.1038/362801a0 · DOI · Paper page
- Simionescu, 1983, Physiol Rev, 63, 1536, 10.1152/physrev.1983.63.4.1536 · DOI · Paper page
- Simionescu, 1991, Targeted Diagn Ther, 5, 45
- Stender, 1981, Arteriosclerosis, 1, 38, 10.1161/01.ATV.1.1.38 · DOI · Paper page
- Steinberg, 1985, Ann N Y Acad Sci, 454, 195, 10.1111/j.1749-6632.1985.tb11858.x · DOI
- Schwenke, 1988, Circ Res, 62, 699, 10.1161/01.RES.62.4.699 · DOI
- Simionescu, 1993, FASEB J, 7, 1359, 10.1096/fasebj.7.14.8224609 · DOI
- Nordestgaard, 1992, Eur J Epidemiol, 8, 92, 10.1007/BF00145358 · DOI
- Mamo, 1994, Coron Artery Dis, 5, 695, 10.1097/00019501-199408000-00008 · DOI
- Proctor, 1996, Coron Artery Dis, 7, 239
- Rutledge, 2000, Circ Res, 86, 768, 10.1161/01.RES.86.7.768 · DOI
- Mamo, 2002, Life Sci, 14, 30
- Roberts, 1996, Circulation, 94, 2248, 10.1161/01.CIR.94.9.2248 · DOI
- Walsh, 2000, J Lipid Res, 41, 134, 10.1016/S0022-2275(20)32083-6 · doi:10.1016/s0022-2275(20)32083-6
- Kovanen, 1999, Trends Cardiovasc Med, 9, 86, 10.1016/S1050-1738(99)00013-4 · DOI
- Mahley, 1999, J Lipid Res, 40, 1, 10.1016/S0022-2275(20)33334-4 · DOI · Paper page
- Boren, 1998, J Clin Invest, 101, 2658, 10.1172/JCI2265 · DOI · Paper page
- Williams, 2001, Curr Opin Lipidol, 12, 477, 10.1097/00041433-200110000-00002 · DOI
- Goldberg, 2001, Front Biosci, 6, D388, 10.2741/Goldberg · DOI · Paper page
- Mamo, 1995, Endocrinol Metab, 2, 229
- Srinivasan, 2001, Atherosclerosis, 159, 391, 10.1016/S0021-9150(01)00514-7 · DOI
- Koba, 2002, Atherosclerosis, 160, 249, 10.1016/S0021-9150(01)00580-9 · DOI
- Rapp, 2002, Cardiol Rev, 10, 163, 10.1097/00045415-200205000-00005 · DOI
- Sniderman, 2001, Ann Intern Med, 135, 447, 10.7326/0003-4819-135-6-200109180-00014 · DOI · Paper page
- Sniderman, 2001, CMAJ, 164, 44
- Schwenke, 1997, Circ Res, 81, 346, 10.1161/01.RES.81.3.346 · doi:10.1161/01.res.81.3.346
- Fielding, 1992, FASEB J, 6, 3162, 10.1096/fasebj.6.13.1327930 · DOI
- Proctor, 2000, Atherosclerosis, 149, 315, 10.1016/S0021-9150(99)00341-X · DOI
- Proctor, 2002, uppl, 3, 159
- OBrien, 1998, Circulation, 98, 519, 10.1161/01.CIR.98.6.519 · DOI · Paper page
- Olin, 2001, Arterioscler Thromb Vasc Biol, 21, 129, 10.1161/01.ATV.21.1.129 · DOI
- Kunjathoor, 2002, Arterioscler Thromb Vasc Biol, 22, 462, 10.1161/hq0302.105378 · DOI
- Raines, 2000, Int J Exp Pathol, 81, 173, 10.1046/j.1365-2613.2000.00155.x · DOI · Paper page
- Iozzo, 1999, J Biol Chem, 274, 18843, 10.1074/jbc.274.27.18843 · DOI · Paper page
- Zilversmit, 1976, Ann N Y Acad Sci, 275, 138, 10.1111/j.1749-6632.1976.tb43348.x · DOI
- Steiner, 1993, Ann Med, 25, 431, 10.3109/07853899309147307 · DOI
- Karpe, 1994, Atherosclerosis, 106, 83, 10.1016/0021-9150(94)90085-X · DOI · Paper page
- Verseyden, 2002, J Lipid Res, 43, 274, 10.1016/S0022-2275(20)30169-3 · DOI
- 1998, J Intern Med, 244, 299, 10.1046/j.1365-2796.1998.00367.x · DOI
- Weintraub, 1996, BMJ, 312, 935, 10.1136/bmj.312.7036.935 · DOI · Paper page
- Groot, 1991, Arterioscler Thromb, 11, 653, 10.1161/01.ATV.11.3.653 · DOI · Paper page
- Mamo, 1998, Eur J Clin Invest, 28, 379, 10.1046/j.1365-2362.1998.00284.x · DOI
- Dane-Stewart, 2001, Eur J Clin Invest, 31, 113, 10.1046/j.1365-2362.2001.00785.x · DOI
- Redgrave, 2001, J Lipid Res, 42, 710, 10.1016/S0022-2275(20)31632-1 · DOI
- Kishi, 2002, Clin Chem, 48, 737, 10.1093/clinchem/48.5.737 · doi:10.1093/clinchem/48.5.737
- Campos, 2002, J Lipid Res, 43, 365, 10.1016/S0022-2275(20)30142-5 · DOI
- Schreuder, 2001, Atherosclerosis, 157, 145, 10.1016/S0021-9150(00)00666-3 · DOI
- Fukushima, 2001, Am J Cardiol, 88, 1370, 10.1016/S0002-9149(01)02115-4 · DOI
- Higashi, 2001, Metabolism, 50, 1462, 10.1053/meta.2001.27193 · DOI
- Jialal, 2002, Clin Chem, 48, 217, 10.1093/clinchem/48.2.217 · DOI
- Mamo, 2001, Am J Physiol Endocrinol Metab, 281, E626, 10.1152/ajpendo.2001.281.3.E626 · DOI
- Chan, 2002, Clin Chem, 48, 217, 10.1093/clinchem/48.2.217 · DOI
- Smith, 1999, Eur J Clin Invest, 29, 204, 10.1046/j.1365-2362.1999.00431.x · DOI
- Olsson, 1999, Diabetes, 48, 616, 10.2337/diabetes.48.3.616 · DOI
- Camejo, 1999, Curr Atheroscler Rep, 1, 142, 10.1007/s11883-999-0010-1 · DOI
- Edwards, 1998, J Geront A Biol Sci Med Sci, 53, B443, 10.1093/gerona/53A.6.B443 · DOI
- Martens, 2002, Drugs, 62, 1463, 10.2165/00003495-200262100-00004 · DOI · Paper page
- Zuckerman, 2002, Lipids, 37, 487, 10.1007/s11745-002-0922-2 · DOI
- Steals, 2002, Nature, 417, 699, 10.1038/417699a · DOI
Cited by
Role of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624
Dyslipidemia in obesity: Mechanisms and potential targets
Klop, B., Elte, J., & Cabezas, M. (2013) · Nutrients · doi:10.3390/nu5041218 · Cited by 1,665
Triglycerides and cardiovascular disease
Nordestgaard, B. G., & Varbo, A. (2014) · The Lancet · doi:10.1016/s0140-6736(14)61177-6 · Cited by 1,419
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Nordestgaard, B. G. (2016) · Circulation Research · doi:10.1161/circresaha.115.306249 · Cited by 1,116
Metadata
- Authors
- Proctor, S. D., Vine, D. F., & Mamo, J. C. L.
- Venue
- Current Opinion in Lipidology
- Published
- 2002-10
- Volume
- 13
- Issue
- 5
- Pages
- 461-470
- ISSN
- 0957-9672 (ISSN-L)
- OpenAlex
- W2009771141
- Cited by
- 201
- References
- 6
- FWCI
- 7.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis. https://app.cochat.ai/papers/10.1097/00041433-200210000-00001
- The paper
- Proctor, S. D., Vine, D. F., & Mamo, J. C. L. (2002). Arterial retention of apolipoprotein B48- and B100-containing lipoproteins in atherogenesis. Current Opinion in Lipidology. https://doi.org/10.1097/00041433-200210000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.